$ News

Third Harmonic Bio Shareholders Approve Liquidation Plan

Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335

Here’s Why Third Harmonic Bio (THRD) Fell in Q1

Third Harmonic outlines plans for dissolution

Third Harmonic Seeks to Liquidate, Dissolve Company

Third Harmonic Bio Announces Plan of Liquidation and Dissolution

Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results

Third Harmonic Bio, Inc. (THRD) Loses -31.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Companies Like Third Harmonic Bio (NASDAQ:THRD) Are In A Position To Invest In Growth

Third Harmonic Bio, Inc. (THRD) Upgraded to Buy: What Does It Mean for the Stock?

Down -39.61% in 4 Weeks, Here's Why You Should You Buy the Dip in Third Harmonic Bio, Inc. (THRD)

Third Harmonic Bio Initiates Strategic Review, Lays Off 50% Staff Citing Competitive Landscape

Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update

Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference

Wall Street Analysts Believe Third Harmonic Bio, Inc. (THRD) Could Rally 26.67%: Here's is How to Trade

Third Harmonic Bio to Participate in Upcoming Investor Conferences in November

Third Harmonic Bio Announces Third Quarter 2024 Financial Results

Biotechnology Value Fund L.P. Reduces Stake in Third Harmonic Bio Inc.

Interesting THRD Call Options For May 2025

Third Harmonic Bio (NASDAQ:THRD) Is In A Strong Position To Grow Its Business